(Q40561968)

21 September 2017

The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells (English)

1 reference

21 September 2017

Panchapakesan U

1

1 reference

PubMed ID

15113752

21 September 2017

Pollock CA

series ordinal

2

1 reference

PubMed ID

15113752

21 September 2017

Chen XM

series ordinal

3

1 reference

21 September 2017

27 April 2004

1 reference

American Journal of Physiology - Renal Physiology

21 September 2017

1 reference

21 September 2017

287

1 reference

21 September 2017

3

1 reference

21 September 2017

F528-34

1 reference

ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.

21 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Physiological and therapeutic roles of peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

The pleiotropic functions of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Albumin and glucose effects on cell growth parameters, albumin uptake and Na(+)/H(+)-exchanger Isoform 3 in OK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Tubulointerstitial changes as a major determinant in the progression of renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Negative growth effects of ciglitazone on kidney interstitial fibroblasts: role of PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Molecular mechanisms of diabetic renal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00445.2003

10.1152/AJPRENAL.00445.2003

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

15113752